Page last updated: 2024-08-25

zoledronic acid and thymalfasin

zoledronic acid has been researched along with thymalfasin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chen, M; Huang, M; Jiao, Y; Pan, J; Sun, Z; Wang, S; Ye, G; Ye, W; Zhang, D; Zhao, J	1

Other Studies

1 other study(ies) available for zoledronic acid and thymalfasin

Article	Year
Zoledronic acid and thymosin α1 elicit antitumor immunity against prostate cancer by enhancing tumor inflammation and cytotoxic T cells. Journal for immunotherapy of cancer, 2023, Volume: 11, Issue:6 Topics: Androgen Antagonists; Androgens; Animals; CD8-Positive T-Lymphocytes; Humans; Inflammation; Male; Mice; Prostatic Neoplasms; Retrospective Studies; T-Lymphocytes, Cytotoxic; Thymalfasin; Tumor Microenvironment; Zoledronic Acid	2023

Article

Year

Zoledronic acid and thymosin α1 elicit antitumor immunity against prostate cancer by enhancing tumor inflammation and cytotoxic T cells.

Journal for immunotherapy of cancer, 2023, Volume: 11, Issue:6

Topics: Androgen Antagonists; Androgens; Animals; CD8-Positive T-Lymphocytes; Humans; Inflammation; Male; Mice; Prostatic Neoplasms; Retrospective Studies; T-Lymphocytes, Cytotoxic; Thymalfasin; Tumor Microenvironment; Zoledronic Acid

2023